U.S. markets open in 7 hours

Instadose Pharma Corp. (INSD)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
2.03000.0000 (0.00%)
At close: 01:37PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close2.0300
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range2.0300 - 2.0300
52 Week Range0.0005 - 60.0000
Avg. Volume62
Market Cap1.08B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0060
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for INSD

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    Analyst Report: Republic Services, Inc.Republic Services is one of the largest domestic provider of nonhazardous waste services, as measured by revenue. The company serves 14 million customers. As of March 31, 2022, it had operations in 41 states. These included 355 collection operations, 238 transfer stations, 198 active landfills, 71 recycling centers, 3 treatment, recovery and disposal facilities, 6 salt water disposal wells, 7 deep injection wells, and 75 landfill gas and renewable energy projects. The average estimated remaining life of the company's landfills is 62 years. The company was founded in 1996 and is based in Phoenix. Republic Services has 35,000 employees. The shares are a component of the S&P 500.
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more
  • PR Newswire

    Instadose US Announces Management Transition

    The Board of Directors of Instadose Pharma Corp., a Nevada corporation, ("Instadose US") announced that effective January 14, 2022, they have accepted the planned resignation of Grant F. Sanders as Chairman and CEO of Instadose US and as Chairman of its wholly owned Canadian subsidiary ("Instadose Canada"). Mr. Sanders will not hold any officer or director positions at Instadose US or Instadose Canada following his resignation.

  • PR Newswire

    Instadose Pharma Corp Ships 2.125 Metric Tons - Largest International Cannabis Delivery in History

    (OTC PINK: INSD) Instadose Pharma Corp (the "company" or "Instadose") Establishing the world largest continual supply of Medicinal Cannabis. Instadose Pharma Corp is extremely proud to announce the delivery of a record-breaking shipment of high-quality Medicinal Cannabis Flower. The delivery of 2.125 Metric Tons was completed on December 25, 2021, from Johannesburg, South Africa to Skopje, North Macedonia. With this successful delivery it establishes Instadose Pharma Corp as a world leader in th


    Instadose Pharma Corp. Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information

    BOSTON, MA / ACCESSWIRE / December 31, 2021 / Block & Leviton announces that a class action lawsuit has been filed against Instadose Pharma Corp. (OTC: INSD) for potential securities law violations.